Notice2022-22887
Opportunity To Co-Sponsor Office of Research Integrity Events
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 21, 2022
Issuing agencies
Health and Human Services Department
Abstract
The Office of Research Integrity (ORI) announces the opportunity for non-federal public and private sector entities to co- sponsor ORI conferences, workshops, symposia, meetings, roundtables, or other such events (collectively, "Events"). ORI co-sponsors a limited number of events with non-federal entities each year. Potential co- sponsors must have demonstrated interest and experience in the responsible conduct of research or handling allegations of research misconduct. Potential co-sponsors must be willing to participate substantively in the co-sponsored event.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 203 (Friday, October 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 203 (Friday, October 21, 2022)]
[Notices]
[Pages 64067-64068]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-22887]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Opportunity To Co-Sponsor Office of Research Integrity Events
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of Research Integrity (ORI) announces the
opportunity for non-federal public and private sector entities to co-
sponsor ORI conferences, workshops, symposia, meetings, roundtables, or
other such events (collectively, ``Events''). ORI co-sponsors a limited
number of events with non-federal entities each year. Potential co-
sponsors must have demonstrated interest and experience in the
responsible conduct of research or handling allegations of research
misconduct. Potential co-sponsors must be willing to participate
substantively in the co-sponsored event.
DATES: Expressions of interest for co-sponsorship of an ORI Event may
be submitted on an ongoing basis throughout the fiscal year (October 1,
2022-September 30, 2023) or beyond.
ADDRESSES: Expressions of interest for co-sponsorship of an ORI Event
should be sent by email to <a href="/cdn-cgi/l/email-protection#8bcaf8e0c4d9c2cbc3c3d8a5ccc4dd"><span class="__cf_email__" data-cfemail="1051637b5f4259505858433e575f46">[email protected]</span></a> with ``Co-sponsorship for ORI
Event'' in the subject field.
FOR FURTHER INFORMATION CONTACT:
Tracey Randolph, Program Analyst, Office of Research Integrity, 1101
Wootton Parkway, Suite 240, Rockville, MD 20852, (240) 453-8200
SUPPLEMENTARY INFORMATION: ORI oversees and directs U.S. Public Health
Service (PHS) research integrity
[[Page 64068]]
activities on behalf of the Secretary of the U.S. Department of Health
and Human Services (HHS), with the exception of the regulatory research
integrity activities of the Food and Drug Administration. ORI is a
program office within the Office of the Assistant Secretary for Health,
Office of the Secretary, HHS.
Core to ORI's mission is the support of education and outreach
activities that aid PHS-funded research institutions in their efforts
``to teach the responsible conduct of research, promote research
integrity, prevent research misconduct, and . . . to respond
effectively to allegations of research misconduct'' (65 FR 30600, 30601
(May 12, 2000)). ORI Events contribute to this mission by providing
education, training, and/or the opportunity for discussion related to
topics such as handling allegations of research misconduct and
fostering research integrity and the responsible conduct of research.
ORI Events typically are moderately sized, usually accepting between 20
and 150 attendees, and convened in person or virtually for one to three
days.
Co-sponsors will work with ORI staff to jointly develop an event.
Both ORI and the co-sponsor must contribute substantively to the
development of the event. Co-sponsors can charge registration fees to
recover costs associated with the events; however, co-sponsors may not
set registration fees at an amount higher than necessary to recover
event-related expenses. Further, co-sponsors are solely responsible for
collecting and handling any registration fees.
Eligibility for Co-Sponsorship: The co-sponsoring entity must have
demonstrated interest and experience in fostering the responsible
conduct of research or handling of research misconduct allegations. The
co-sponsoring entity must participate substantively in the co-sponsored
activity, and not just provide funding, logistical services, or other
material support.
Expression of Interest in Co-Sponsorship: An entity shall provide
an expression of interest that includes (1) one to two paragraphs
detailing why ORI should select the entity, including the entity's
leadership in and management of matters involving research integrity
and the responsible conduct of research, and (2) a bulleted outline
addressing the seven topics listed below. The expression of interest
should be one to two pages in length, single-spaced, and at least 11-
point font. An entity may submit an expression of interest individually
or jointly with other entities describing their relative contributions.
The seven topics to be addressed in the outline are:
1. The entity's interest and goals in promoting research integrity and/
or the responsible conduct of research
2. The entity's prior experience and current readiness to undertake the
responsibilities described above
3. The type of event(s) that the entity is interested in co-sponsoring
with ORI
4. Facilities available for the event(s), including the distance from
the facilities to a major airport
5. Any current constraints with respect to dates or facilities
6. Whether the entity has co-sponsored an ORI Event in the past 36
months
7. Whether the entity has any cases, allegations, or other related
matters pending with ORI
Evaluation Criteria: After engaging in exploratory discussions with
potential co-sponsors who respond to this notice, HHS will apply the
following considerations, as appropriate and relevant, to select the
co-sponsor(s):
<bullet> Qualifications and capability to fulfill co-sponsorship
responsibilities
<bullet> Suitability of the location of the proposed event in terms of
the overall geographical distribution of recent or planned ORI Events
<bullet> Potential for reaching, generating, and engaging an adequate
number of attendees
<bullet> Availability and description of facilities needed to support
the event
<bullet> Availability of administrative support for the logistics of
hosting such events
The duties of the co-sponsor will be outlined in a co-sponsorship
agreement with ORI that will set forth the details of the co-sponsored
event, including the requirements that any fees collected by the co-
sponsor shall be limited to the amount necessary to cover the co-
sponsor's event-related expenses. This co-sponsorship agreement does
not represent an endorsement by ORI of an individual co-sponsor's
policies, positions, or activities.
Dated: October 13, 2022.
Wanda K. Jones,
Acting Director, Office of Research Integrity, Office of the Assistant
Secretary for Health.
[FR Doc. 2022-22887 Filed 10-20-22; 8:45 am]
BILLING CODE 4150-31-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 21, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.